ArticleCureus2025
Benign Acute Childhood Myositis: A Three-Year Experience From a Pediatric Department in Poland.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Hospitalized Versus Outpatient Benign Acute Childhood Myositis: A 10-Year Single-Center Experience.Medicina (Kaunas, Lithuania) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Benign acute childhood myositis (BACM) is a condition characterized by the sudden onset of bilateral lower limb muscle pain and gait disturbances, usually appearing a few days after a viral flu-like illness. Although most often linked to influenza virus infection, various other pathogens have also been reported. The disease mainly affects children during late autumn, winter, and early spring. Laboratory findings often show temporary elevation of muscle enzymes, particularly creatine kinase (CK) and aspartate aminotransferase (AST). Despite its striking presentation, BACM is self-limiting with an excellent prognosis and typically requires only supportive care, including rest, hydration, and analgesia. A key clinical challenge is distinguishing BACM from rhabdomyolysis, a more serious condition involving extensive muscle breakdown, which can lead to worsening general condition, altered consciousness, and acute kidney injury. This retrospective study analyzes the clinical and laboratory features of children diagnosed with BACM and hospitalized between April 2022 and April 2025 in the Clinical Department of Pediatrics in Bytom, Poland. To identify similarities and differences, the findings were compared with data from other studies in international medical databases. Overall, the study conclusions were consistent with previously published literature.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.